NVIV Annual Total Expenses
$10.65 M
+$750.00 K+7.58%
31 December 2022
Summary:
As of February 5, 2025, NVIV annual total expenses is $10.65 million, with the most recent change of +$750.00 thousand (+7.58%) on December 31, 2022. During the last 3 years, it has fallen by -$847.00 thousand (-7.37%).NVIV Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVIV Quarterly Total Expenses
$2.83 M
+$743.00 K+35.64%
30 September 2023
Summary:
As of February 5, 2025, NVIV quarterly total expenses is $2.83 million, with the most recent change of +$743.00 thousand (+35.64%) on September 30, 2023. Over the past year, it has increased by +$28.00 thousand (+1.00%).NVIV Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVIV Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.6% | +1.0% |
| 3 y3 years | -7.4% | +23.9% |
| 5 y5 years | -56.7% | +33.8% |
NVIV Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -56.7% | -59.2% |
InVivo Therapeutics Holdings Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $2.83 M(+35.6%) |
| June 2023 | - | $2.08 M(-16.2%) |
| Mar 2023 | - | $2.49 M(+1.3%) |
| Dec 2022 | $10.65 M(+7.6%) | $2.46 M(-12.3%) |
| Sept 2022 | - | $2.80 M(+2.6%) |
| June 2022 | - | $2.73 M(+2.4%) |
| Mar 2022 | - | $2.67 M(-8.5%) |
| Dec 2021 | $9.90 M(+8.8%) | $2.91 M(+18.8%) |
| Sept 2021 | - | $2.45 M(+6.2%) |
| June 2021 | - | $2.31 M(+3.9%) |
| Mar 2021 | - | $2.22 M(+1.5%) |
| Dec 2020 | $9.10 M(-20.9%) | $2.19 M(-4.0%) |
| Sept 2020 | - | $2.28 M(+4.0%) |
| June 2020 | - | $2.19 M(-9.6%) |
| Mar 2020 | - | $2.43 M(-11.4%) |
| Dec 2019 | $11.50 M(-9.9%) | $2.74 M(+0.3%) |
| Sept 2019 | - | $2.73 M(-15.9%) |
| June 2019 | - | $3.25 M(+16.9%) |
| Mar 2019 | - | $2.78 M(-7.7%) |
| Dec 2018 | $12.77 M(-48.1%) | $3.01 M(+42.5%) |
| Sept 2018 | - | $2.11 M(-24.9%) |
| June 2018 | - | $2.81 M(-41.8%) |
| Mar 2018 | - | $4.83 M(+3.2%) |
| Dec 2017 | $24.59 M(+2.2%) | $4.68 M(-25.9%) |
| Sept 2017 | - | $6.32 M(-8.8%) |
| June 2017 | - | $6.93 M(+3.9%) |
| Mar 2017 | - | $6.67 M(-2.4%) |
| Dec 2016 | $24.06 M(+7.4%) | $6.83 M(+16.2%) |
| Sept 2016 | - | $5.88 M(+1.6%) |
| June 2016 | - | $5.79 M(+3.9%) |
| Mar 2016 | - | $5.57 M(+5.9%) |
| Dec 2015 | $22.40 M(+25.6%) | $5.26 M(-10.4%) |
| Sept 2015 | - | $5.87 M(+1.9%) |
| June 2015 | - | $5.76 M(+4.5%) |
| Mar 2015 | - | $5.51 M(+43.4%) |
| Dec 2014 | $17.84 M | $3.84 M(-8.1%) |
| Sept 2014 | - | $4.18 M(-11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $4.74 M(-6.5%) |
| Mar 2014 | - | $5.07 M(-10.6%) |
| Dec 2013 | $19.00 M(+48.7%) | $5.67 M(+5.0%) |
| Sept 2013 | - | $5.41 M(+6.6%) |
| June 2013 | - | $5.07 M(+77.9%) |
| Mar 2013 | - | $2.85 M(-39.6%) |
| Dec 2012 | $12.78 M(+47.6%) | $4.72 M(+66.2%) |
| Sept 2012 | - | $2.84 M(+3.1%) |
| June 2012 | - | $2.76 M(+12.0%) |
| Mar 2012 | - | $2.46 M(-2.2%) |
| Dec 2011 | $8.66 M(+154.9%) | $2.52 M(+13.7%) |
| Sept 2011 | - | $2.21 M(-12.4%) |
| June 2011 | - | $2.53 M(+80.4%) |
| Mar 2011 | - | $1.40 M(+5809.7%) |
| Dec 2010 | $3.40 M(+5955.8%) | - |
| Sept 2010 | - | $23.70 K(-9.5%) |
| June 2010 | - | $26.20 K(+285.3%) |
| Mar 2010 | - | $6800.00(+11.5%) |
| Mar 2010 | $56.10 K(-13.0%) | - |
| Dec 2009 | - | $6100.00(-29.9%) |
| Sept 2009 | - | $8700.00(-74.8%) |
| June 2009 | - | $34.50 K(-9.2%) |
| Mar 2009 | $64.50 K(+81.2%) | $38.00 K(+1087.5%) |
| Dec 2008 | - | $3200.00(-203.2%) |
| Sept 2008 | - | -$3100.00(-115.3%) |
| June 2008 | - | $20.20 K(-23.5%) |
| Mar 2008 | $35.60 K(-92.1%) | $26.40 K(+300.0%) |
| Dec 2007 | - | $6600.00(>+9900.0%) |
| Sept 2007 | - | $0.00(-100.0%) |
| June 2007 | - | $4200.00(-98.8%) |
| Mar 2007 | $452.00 K(+1225.5%) | $347.40 K(+930.9%) |
| Dec 2006 | - | $33.70 K(-33.7%) |
| Sept 2006 | - | $50.80 K(+151.5%) |
| June 2006 | - | $20.20 K(-4.7%) |
| Mar 2006 | $34.10 K | $21.20 K(+315.7%) |
| Dec 2005 | - | $5100.00(-1.9%) |
| Sept 2005 | - | $5200.00 |
FAQ
- What is InVivo Therapeutics Holdings annual total expenses?
- What is the all time high annual total expenses for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings annual total expenses year-on-year change?
- What is InVivo Therapeutics Holdings quarterly total expenses?
- What is the all time high quarterly total expenses for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings quarterly total expenses year-on-year change?
What is InVivo Therapeutics Holdings annual total expenses?
The current annual total expenses of NVIV is $10.65 M
What is the all time high annual total expenses for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high annual total expenses is $24.59 M
What is InVivo Therapeutics Holdings annual total expenses year-on-year change?
Over the past year, NVIV annual total expenses has changed by +$750.00 K (+7.58%)
What is InVivo Therapeutics Holdings quarterly total expenses?
The current quarterly total expenses of NVIV is $2.83 M
What is the all time high quarterly total expenses for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high quarterly total expenses is $6.93 M
What is InVivo Therapeutics Holdings quarterly total expenses year-on-year change?
Over the past year, NVIV quarterly total expenses has changed by +$28.00 K (+1.00%)